N@N

MAKO SURGICAL CORP (NASDAQ:MAKO), Up By 9.49% ($2.28) From $24.030 After BUYINS.NET Report Predicted Strength After Earnings

_{//stocks-investing.news-articles.net/content/201 .. et-report-predicted-strength-after-earnings.html}
^{Published in Stocks and Investing on Tuesday, August 9th 2011 at 7:26 GMT by WOPRAI}  

August 9, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Friday, August 5th 2011 stating that MAKO SURGICAL CORP (NASDAQ:MAKO) was expected to be Up After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=mako&id=183342

At the time this story was written, MAKO SURGICAL CORP (NASDAQ:MAKO) is Up By 9.49% ($2.28) From $24.030 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

MAKO SURGICAL CORP (NASDAQ:MAKO) - MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures primarily in the United States. It offers MAKOplasty, a restorative surgical solution, which enables orthopedic surgeons to treat patient specific early to mid-stage osteoarthritic knee disease. The company also provides robotic arm interactive orthopedic system consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component that offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling minimally invasive, tissue sparing bone removal and knee implant insertion. In addition, it provides tactile guidance system for use with an inlay knee implant system. Further, the company offers the RESTORIS family of knee implant systems comprising unicompartmental knee implant system and multicompartmental knee implant system that are designed for insertion and cementation in a minimally invasive manner. MAKO Surgical Corp. markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. The company was incorporated in 2004 and is headquartered in Fort Lauderdale, Florida.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MAKO SURGICAL CORP (NASDAQ:MAKO) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net